Effective classification and gene expression profiling for the Facioscapulohumeral Muscular Dystrophy

The Facioscapulohumeral Muscular Dystrophy (FSHD) is an autosomal dominant neuromuscular disorder whose incidence is estimated in about one in 400,000 to one in 20,000. No effective therapeutic strategies are known to halt progression or reverse muscle weakness and atrophy. It is known that the FSHD...

Ausführliche Beschreibung